Seasonal allergic rhinoconjunctivitis (hay fever), perennial allergic rhinoconjunctivitis, urticaria

Indication for Mizolastine

Population group: Suitable for both men and women, only adolescents (12 years - 18 years old) , adults (18 years old or older)
Therapeutic intent: Curative procedure

Mizolastine is a long-acting H1-antihistamine indicated for the symptomatic relief of seasonal allergic rhinoconjunctivitis (hay fever), perennial allergic rhinoconjunctivitis and urticaria.

For this indication, competent medicine agencies globally authorize below treatments:

10 mg once daily

For: Adolescents Adults (18-64) Elders (65+)

Dosage regimens

Oral, 10 milligrams, daily, one dose.

Detailed description

Adults, including the elderly, and children 12 years of age and over: The recommended daily dose is one 10 mg tablet.

Active ingredient

Mizolastine possesses antihistamine and antiallergic properties due to a specific and selective antagonism of peripheral histamine H1 receptors.

Read more about Mizolastine

Related medicines

Summary of Product Characteristics (SPC) 2021: MIZOLLEN Modified-release tablet

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner